Cefadroxil/cefadroxil hemihydrate - Generic Drug Details

What are the generic drug sources for cefadroxil/cefadroxil hemihydrate and what is the scope of patent protection?

Cefadroxil/cefadroxil hemihydrate is the generic ingredient in three branded drugs marketed by Aurobindo Pharma, Chartwell Rx, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Warner Chilcott, Bristol, Ani Pharms, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

Nineteen suppliers are listed for this compound.

Summary for cefadroxil/cefadroxil hemihydrate

US Patents:	0
Tradenames:	3
Applicants:	19
NDAs:	30
Finished Product Suppliers / Packagers:	19
Raw Ingredient (Bulk) Api Vendors:	69
Patent Applications:	6,444
DailyMed Link:	cefadroxil/cefadroxil hemihydrate at DailyMed

Pharmacology for cefadroxil/cefadroxil hemihydrate

Drug Class

Cephalosporin Antibacterial

US Patents and Regulatory Information for cefadroxil/cefadroxil hemihydrate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	FOR SUSPENSION;ORAL	065396-002	Feb 21, 2008	AB	RX	No	Yes
Apothecon	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	FOR SUSPENSION;ORAL	062334-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Teva	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	CAPSULE;ORAL	062695-001	Feb 10, 1989		DISCN	No	No
Warner Chilcott	DURICEF	cefadroxil/cefadroxil hemihydrate	FOR SUSPENSION;ORAL	050527-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Sun Pharm Inds Ltd	CEFADROXIL	cefadroxil/cefadroxil hemihydrate	FOR SUSPENSION;ORAL	065115-003	Mar 26, 2003		DISCN	No	No